000 01211 a2200349 4500
005 20250518091211.0
264 0 _c20200724
008 202007s 0 0 eng d
022 _a1536-0229
024 7 _a10.1097/RLU.0000000000002977
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLópez-Mora, Diego Alfonso
245 0 0 _aThe Added Value of Tau-PET in the Assessment of Progressive Supranuclear Palsy.
_h[electronic resource]
260 _bClinical nuclear medicine
_cMay 2020
300 _ae239-e240 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aAminopyridines
650 0 4 _aFluorodeoxyglucose F18
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPositron-Emission Tomography
650 0 4 _aQuinolines
650 0 4 _aSupranuclear Palsy, Progressive
_xdiagnostic imaging
650 0 4 _atau Proteins
_xmetabolism
700 1 _aFernández León, Alejandro
700 1 _aLleó, Alberto
700 1 _aBlesa, Rafael
700 1 _aCamacho, Valle
773 0 _tClinical nuclear medicine
_gvol. 45
_gno. 5
_gp. e239-e240
856 4 0 _uhttps://doi.org/10.1097/RLU.0000000000002977
_zAvailable from publisher's website
999 _c30720380
_d30720380